Platelet P2Y12 receptor antagonist pharmacokinetics and pharmacodynamics: A foundation for distinguishing mechanisms of bleeding and anticipated risk for platelet-directed therapies

Thrombosis and Haemostasis
Richard C Becker, Paul A Gurbel

Abstract

The platelet P2Y12 receptor is involved in all aspects of arterial thrombosis, including adhesion, activation, aggregation, secretion and development of a stable aggregate on which coagulation proteins can assemble and fibrin strands can mesh. Inhibition of the P2Y12 receptor has been shown convincingly to reduce cardiovascular events among patients with acute coronary syndromes (ACS) and in patients undergoing percutaneous intervention (PCI). Current studies are exploring whether there is a threshold of platelet aggregation below which only more bleeding occurs, without a concomitant reduction in clinical events. The following review considers the potential relevance of reversible and irreversible mechanisms of P2Y12 inhibition to bleeding risk, posing the question, "Is it not only how much but how a platelet P2Y12 receptor is inhibited that determines the attributable safety profile?"

Citations

May 11, 2011·Veterinary Clinical Pathology·Mary K Boudreaux, Monica Martin
Apr 29, 2014·PloS One·Marine GoffinetRudi Baron
Nov 26, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·David IyúStan Heptinstall
Oct 4, 2012·Expert Review of Cardiovascular Therapy·Mark J AntoninoPaul A Gurbel
Jan 15, 2011·Platelets·Soochong Kim, Satya P Kunapuli
Jul 20, 2011·Nature Reviews. Cardiology·Udaya S Tantry, Paul A Gurbel
Aug 27, 2011·Journal of Medicinal Chemistry·Kamil KamińskiRadosław Lach
Dec 24, 2011·Biochemistry·Joshua E SokoloskiPhilip C Bevilacqua

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.